FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706931015 | CGPR antagonist | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3706932010 | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3706933017 | Calcitonin gene-related peptide receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Calcitonin gene-related peptide receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Is a | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Calcitonin gene-related peptide receptor antagonist-containing product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | 1 |
| Erenumab | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Fremanezumab (substance) | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Galcanezumab | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Ubrogepant (substance) | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Rimegepant | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Eptinezumab (substance) | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Rimegepant sulfate | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some | |
| Atogepant | Is a | True | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Inferred relationship | Some |
This concept is not in any reference sets